Grimolobium pubescens
Grimolobium pubescens · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Grimolobium pubescens is a botanical species that has garnered significant attention within pharmacological research due to its potential therapeutic properties. Scientific investigations have focused specifically on its efficacy in managing conditions related to Type 2 Diabetes. Researchers primarily utilize crude extracts and refined extracts to study the plant's bioactive compounds. These preparations are analyzed to determine how they might influence glucose regulation and metabolic stability. Understanding the medicinal potential of this plant offers promising avenues for future diabetic treatments.
- Synonyms
- Otholobium Pubescens · Psoralea Marginata · 11 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Grimolobium pubescens is a unique botanical species widely recognized by its traditional common name, 秘魯補骨脂. This plant holds a significant place in regional herbal knowledge due to its specific biological characteristics. By connecting its scientific identity to its local nomenclature, researchers can better understand its cultural and ecological context. Studying these linguistic and botanical relationships provides essential insights into how various communities categorize natural resources. Consequently, mastering the relationship between its formal classification and its common name is vital for accurate botanical documentation.
Sources: Catalogue of Life (COL)
Synonyms
Grimolobium pubescens is a botanical subject characterized by a complex history of taxonomic classifications. Throughout various studies, this species has been identified by several different names, including the synonyms Hoita hirsuta and Hoita versicolor. Researchers have also categorized it under the designation Lotodes marginatum in past literature. Furthermore, the plant is linked to the names Otholobium pubescens and Psoralea featherstonei within botanical records. Understanding these shifting relationships is essential for accurately tracking the plant's scientific identity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Grimolobium pubescens is a fascinating member of the kingdom Plantae that belongs to the class Equisetopsida. This unique plant is categorized under the order Fabales, showcasing its specific evolutionary placement. Within this order, it is further classified into the family Fabaceae, a group known for its diverse botanical characteristics. The species is the primary representative of its own genus, known as Grimolobium. Understanding these taxonomic relationships provides essential insight into the biological identity of this remarkable organism.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Grimolobium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Grimolobium pubescens is a plant species widely distributed throughout various regions of Southern America. Its presence is particularly noted across the southern stretches of the continent, specifically within northern Chile. The species also extends its reach into Western South America, where it can be found thriving in Bolivia. Furthermore, its natural habitat encompasses significant portions of Peru. This broad geographic range highlights the adaptability of the plant across diverse South American landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Conditions
Grimolobium pubescens, identified in the research as Otholobium pubescens, serves as a Peruvian medicinal plant used for the treatment of diabetes. The bioactive compound bakuchiol was isolated from this plant to demonstrate significant antihyperglycemic activity. In studies involving the db/db mouse model, oral administration of this compound effectively reduced blood glucose levels. Furthermore, the plant's extracts showed promise in treating type 2 diabetes within fat-fed, streptozotocin-treated rat models. These findings confirm that the plant's components significantly lower both plasma glucose and triglyceride levels.
Preparations
Grimolobium pubescens is prepared as extracts for biological testing within the study of Peruvian medicinal plants. Specifically, the plant is processed into ethanol extracts to evaluate its potential therapeutic properties. These preparations are utilized to assess antiproliferative activity against human hepatocellular carcinoma cell lines. Furthermore, the research involves the use of crude extracts to examine phenotypic modifications in cellular structures. These extraction methods allow for a detailed analysis of how the plant's components interact with Hep3B cells.